Non-steroidal anti-inflammatory drugs

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

• Revision history
  • Revised July 22, 2022; June 2020; June 2018; August 2016; June 2016; October 2014; February 2013; December 2012; March 2011; January 2011; October 2007; January 2006; August 2003; September 2002; August 2001; September 2000; August 2000; November 1999; October 1999; September 1998; September 1997; October 1996; October 1995.
• Initially developed
  • January 1994